Source: Talent4Boards

Cardurion: Cardurion Pharmaceuticals appoints Pete Lawrence as CEO alongside Dr Michael Mendelsohn remaining Chairman of the Board of Directors

Talent4Boards - Great Talent builds Great Boards- USA, MA - Cardurion Pharmaceuticals, Inc. a clinical-stage biotechnology company focused on discovering and developing next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced the appointment of Peter S. Lawrence as president and CEO. Mr. Lawrence joins Cardurion after serving for almost 14 years ...Read moreCardurion Pharmaceuticals appoints Pete Lawrence as CEO alongside Dr Michael Mendelsohn remaining Chairman of the Board of DirectorsCardurion Pharmaceuticals appoints Pete Lawrence as CEO alongside Dr Michael Mendelsohn remaining Chairman of the Board of Directors

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Peter S. Lawrence's photo - President & CEO of Cardurion

President & CEO

Peter S. Lawrence

CEO Approval Rating

88/100

Read more